<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/320A95D7-E544-4371-ACAC-D706B4093FD6"><gtr:id>320A95D7-E544-4371-ACAC-D706B4093FD6</gtr:id><gtr:firstName>David Anthony</gtr:firstName><gtr:surname>Price</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G108%2F441"><gtr:id>61C6EBD4-668C-40A2-B1A1-B6BAF71471A4</gtr:id><gtr:title>Novel Methodologies to Address Key Pathogenetic and Clinical Issues in Primary HIV-1 Infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G108/441</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>25269</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Paris</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>44BB4865-01ED-41D9-989A-AAC9A92ED1BB</gtr:id><gtr:impact>H&amp;ocirc;pital Piti&amp;eacute;-Salp&amp;ecirc;tri&amp;egrave;re, Universit&amp;eacute; Pierre et Marie Curie, Paris, France

Collaboration</gtr:impact><gtr:outcomeId>30F5C35E579</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presenter - Denver</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>6A3A6A9D-B22A-4EC4-995F-166656462851</gtr:id><gtr:impact>Price D, Wooldridge L, Gostick E, Oxenius A, Brenchley J, Glick M, Boulter J, van den Berg H, Douek D, Sewell A (2006). Enhanced antigenicity of HIV-derived CD8+ T-cell epitopes presented by major histocompatibility complex class I proteins with increased co-receptor binding properties. In: Program and Abstracts of the 13th Conference on Retroviruses and Opportunistic Infections [p196; abstract #436], Denver, Colorado, USA.

Collaboration.</gtr:impact><gtr:outcomeId>DC3DF02E3CC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Santorini</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>39F81AFC-4553-44C2-AE7E-6A6085FEAE9B</gtr:id><gtr:impact>Price DA, Wooldridge L, Gostick E, Hutchinson SL, Laugel B, van den Berg HA, Glick M, Douek DC, Brenchley JM, Boulter JM, Sewell AK (2006). Functional and physical effects of altered CD8 coreceptor engagement by peptide-MHC class I molecules. In: Program and Abstracts of the Measurement of Antigen-Specific Immune Responses (MASIR) Meeting [p28; abstract #S5], Fira, Santorini, Greece.

Collaboration.</gtr:impact><gtr:outcomeId>E6AE8518221</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Stockholm</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>4C644A67-CE4F-4D81-9516-67A8B8B39F45</gtr:id><gtr:impact>Center for Infectious Medicine, Karolinska Institute, Stockholm, Sweden

Collaboration</gtr:impact><gtr:outcomeId>942F739EFF9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presenter - Keystone</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>C63376FB-7B47-490D-9310-04D88BED128E</gtr:id><gtr:impact>Price DA, Wooldridge L, Glick M, Boulter JM, van den Berg HA, Oxenius A, Douek DC, Gostick E, Sewell AK (2006). Functional consequences of peptide-major histocompatibility complex class I antigen presentation in the context of enhanced CD8 coreceptor binding: implications for vaccine delivery. In: Program and Abstracts of the Keystone Symposium on HIV Vaccines [p221; abstract #339], Keystone, Colorado, USA.

Collaboration</gtr:impact><gtr:outcomeId>52942539DB0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Bethesda</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>EF69F363-F8D2-472E-BD7D-EAC2FF4BED95</gtr:id><gtr:impact>Hematology Branch, NHLBI/NIH, Bethesda MD, USA

Collaboration.</gtr:impact><gtr:outcomeId>04254AE9953</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Bethesda</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>16183289-E592-4B4B-A155-243E34453D2F</gtr:id><gtr:impact>Surgery Branch, NCI/NIH, Bethesda MD, USA

Collaboration</gtr:impact><gtr:outcomeId>60B121489A4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1977040</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Senior Clinical Fellowship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0501963</gtr:fundingRef><gtr:id>8D043556-D06A-44B2-8CE5-412AA54C7B4F</gtr:id><gtr:outcomeId>E6A7DA376A70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>464850A7-0362-46EC-BD17-C2A76FE20AC8</gtr:id><gtr:title>In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteins.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4df6eedc21eb8e8c27079bb8947b7720"><gtr:id>4df6eedc21eb8e8c27079bb8947b7720</gtr:id><gtr:otherNames>Fujiwara H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>EB90587CABF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>799C930B-5D09-46D0-B70C-E24EBA7EAE4D</gtr:id><gtr:title>Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f914890c0d1eb6448e1de72e90a49d9e"><gtr:id>f914890c0d1eb6448e1de72e90a49d9e</gtr:id><gtr:otherNames>Joos B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>4B5A05C9885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8AA8B66-3977-4980-8BF8-A24471653C78</gtr:id><gtr:title>Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d547e90cc384e09a297316e7446f9b8"><gtr:id>6d547e90cc384e09a297316e7446f9b8</gtr:id><gtr:otherNames>Wooldridge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>2DBF2F6AB4A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20B1E844-32F2-458B-B8ED-CD75B25A2466</gtr:id><gtr:title>Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f5676bad8e51dedd8e69c5b564efbd"><gtr:id>64f5676bad8e51dedd8e69c5b564efbd</gtr:id><gtr:otherNames>Venturi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>317EB772346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>525E4A3F-3369-461F-A48C-F1CE4E8324EC</gtr:id><gtr:title>Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineering.</gtr:title><gtr:parentPublicationTitle>Experimental hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6d1393dc2eefe070ba1cd2394a1522c"><gtr:id>c6d1393dc2eefe070ba1cd2394a1522c</gtr:id><gtr:otherNames>Scheinberg P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0301-472X</gtr:issn><gtr:outcomeId>A673FA5FBF3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25A53FE7-7E02-46DD-A13C-E160A84BB789</gtr:id><gtr:title>Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c086cf57166823f47a0a3f368315a4bb"><gtr:id>c086cf57166823f47a0a3f368315a4bb</gtr:id><gtr:otherNames>Casazza JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>CDFB9F5C78C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3696939-D233-47E7-B9E6-2857A6ECF034</gtr:id><gtr:title>Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a610b8cc0953c3fc751032a93b0d84f"><gtr:id>7a610b8cc0953c3fc751032a93b0d84f</gtr:id><gtr:otherNames>Price DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>4B7849B89F1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF914BD5-6470-47C3-B891-956816A76282</gtr:id><gtr:title>Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3c94fbc9ddd535d68295fce9965dad9"><gtr:id>c3c94fbc9ddd535d68295fce9965dad9</gtr:id><gtr:otherNames>Betts MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>1B1CA2BFCC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4CFD9ED-4E77-4C38-8FEF-F73DC8DE5D35</gtr:id><gtr:title>High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03b3c5c73473125998595b41769dd1c5"><gtr:id>03b3c5c73473125998595b41769dd1c5</gtr:id><gtr:otherNames>Ellmerich S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>A74415109DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FE29C65-BED7-4EA5-9E0A-8EBF677D8D29</gtr:id><gtr:title>PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/833871a2c9f973bae8866fd14b00c736"><gtr:id>833871a2c9f973bae8866fd14b00c736</gtr:id><gtr:otherNames>Petrovas C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>F77FEF847C6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>524D784A-892A-41A6-8F35-D1C032B85FA4</gtr:id><gtr:title>Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1ea982163d0726daa0974c5fc5467b"><gtr:id>0b1ea982163d0726daa0974c5fc5467b</gtr:id><gtr:otherNames>Brenchley JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>0348AA28A83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6610F9F5-696E-4492-A743-E76226753F73</gtr:id><gtr:title>The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7dbdd4a160dd45356513aafa60ef87a"><gtr:id>a7dbdd4a160dd45356513aafa60ef87a</gtr:id><gtr:otherNames>Hewitt RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>47933FB8B2D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DDA0980-9936-481B-B6C6-A7CA64D027E3</gtr:id><gtr:title>Microbial translocation is a cause of systemic immune activation in chronic HIV infection.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1ea982163d0726daa0974c5fc5467b"><gtr:id>0b1ea982163d0726daa0974c5fc5467b</gtr:id><gtr:otherNames>Brenchley JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>2C18A223B5D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BAD2774-2BCF-4246-A8F4-B2703F08C94D</gtr:id><gtr:title>On the path to TCR-directed therapeutics.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1cd528ca89a12d59e44186f2e5891f"><gtr:id>3c1cd528ca89a12d59e44186f2e5891f</gtr:id><gtr:otherNames>Laugel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>7D923BA60B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB41DCBD-F458-4464-88A8-FB1719620DCD</gtr:id><gtr:title>Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4a9129b422b0a859f595824afc4bd31"><gtr:id>d4a9129b422b0a859f595824afc4bd31</gtr:id><gtr:otherNames>Chattopadhyay PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>7B0C96BD77D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F215A164-0F71-47DE-BBEE-505F3FC3440C</gtr:id><gtr:title>T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/234d5bc1f623b6837834e29975ccab92"><gtr:id>234d5bc1f623b6837834e29975ccab92</gtr:id><gtr:otherNames>Rezvani K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>DC3C3008E91</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C187F253-53E4-4A5E-9009-9F5278D4AEBC</gtr:id><gtr:title>Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bf75c8134a1b281eac30db272b13e5f"><gtr:id>8bf75c8134a1b281eac30db272b13e5f</gtr:id><gtr:otherNames>Kan-Mitchell J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>03255B144FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D51E21A6-C34C-4618-B2F2-8168A7618B97</gtr:id><gtr:title>HIV disease: fallout from a mucosal catastrophe?</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1ea982163d0726daa0974c5fc5467b"><gtr:id>0b1ea982163d0726daa0974c5fc5467b</gtr:id><gtr:otherNames>Brenchley JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>129DDE5CD94</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4B33C9E-35F2-4D80-B007-1B6D2BAB24E3</gtr:id><gtr:title>Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d547e90cc384e09a297316e7446f9b8"><gtr:id>6d547e90cc384e09a297316e7446f9b8</gtr:id><gtr:otherNames>Wooldridge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>0B8041874DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D0A4851-7887-43B0-B415-119B7CBCB694</gtr:id><gtr:title>Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c086cf57166823f47a0a3f368315a4bb"><gtr:id>c086cf57166823f47a0a3f368315a4bb</gtr:id><gtr:otherNames>Casazza JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>08C3F9FB15B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDBBDA88-E848-4BED-B29B-1E9B031504C9</gtr:id><gtr:title>CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfadc819c928ceed313defc7cda06fae"><gtr:id>bfadc819c928ceed313defc7cda06fae</gtr:id><gtr:otherNames>Milicic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>EED78C38DDE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC8E1455-5065-439A-BECB-101D5D6F1280</gtr:id><gtr:title>Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38fbfa37bb1008fe3395f2c7fe0b9417"><gtr:id>38fbfa37bb1008fe3395f2c7fe0b9417</gtr:id><gtr:otherNames>Leslie A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>8107F4A7610</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G108/441</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>200</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>200</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>